Disease models from pluripotent stem cells: Turning back time in disease pathogenesis

Annals of the New York Academy of Sciences

Volumn 1176, Issue , 2009, Pages 191-196

  Lengerke, Claudia ^a   Daley, George Q ^b,c,d,e,f  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

^f Manton Center for Orphan Disease Research   (United States)

Author keywords

Disease models; Disease specific pluripotent stem cells; Human embryonic stem cells; Human induced pluripotent stem cells

Indexed keywords

CELL DIFFERENTIATION; CONFERENCE PAPER; DISEASE MODEL; EMBRYONIC STEM CELL; GENETIC DISORDER; GENETIC TRANSDUCTION; HUMAN; LENTIVIRINAE; NONHUMAN; PATHOPHYSIOLOGY; PLURIPOTENT STEM CELL; SOMATIC CELL;

IPS; MURINAE;

EID: 70349815098     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04962.x     Document Type: Conference Paper

References (39)

1. Nelson, D.L. & R.A. Gibbs. 2004. Genetics. The critical region in trisomy 21. Science 306: 619-621.
2. Olson, L.E., J.T. Richtsmeier, J. Leszl & R.H. Reeves. 2004. A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306: 687-690.
3. Alter, B.P. 1996. Fanconi's anemia and malignancies. Am. J. Hematol. 53: 99-110.
4. Chen, M., D.J. Tomkins, W. Auerbach, et al. 1996. Inactivation of Fac in mice produces inducible chro-mosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12: 448-451.
5. Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, et al. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
6. Murry, C.E. & G. Keller. 2008. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680.
7. Tischkowitz, M. & I. Dokal. 2004. Fanconi anaemia and leukaemia - clinical and molecular aspects. Br. J. Haematol. 126: 176-191.
8. Urbach, A., M. Schuldiner & N. Benvenisty. 2004. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 22: 635-641. (Pubitemid 39014579)
9. Zwaka, T.P. & J.A. Thomson. 2003. Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 21: 319-321.
10. Zaehres, H., M.W. Lensch, L. Daheron, et al. 2005. High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23: 299-305.
11. Tulpule, A. & G.Q. Daley. 2009. Efficient gene knockdowns in human embryonic stem cells using lentiviral-based RNAi. Methods Mol. Biol. 482: 35-42.
12. Verlinsky, Y., N. Strelchenko, V. Kukharenko, et al. 2005. Human embryonic stem cell lines with genetic disorders. Reprod. Biomed. Online 10: 105-110.
13. Eiges, R., A. Urbach, M. Malcov, et al. 2007. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1: 568-577.
14. Urbach, A. & N. Benvenisty. 2009. Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS ONE 4: e4175.
15. Bittles, A.H., C. Bower, R. Hussain & E.J. Glasson. 2007. The four ages of Down syndrome. Eur. J. Public Health 17: 221-225.
16. Park, I.H., N. Arora, H. Huo, et al. 2008. Disease-specific induced pluripotent stem cells. Cell 134: 877-886.
17. Mali, P., Z. Ye, H.H. Hommond, et al. 2008. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 26: 1998-2005.
18. Takahashi, K. & S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
19. Park, I.H., P.H. Lerou, R. Zhao, et al. 2008. Generation of human-induced pluripotent stem cells. Nat. Protoc. 3: 1180-1186.
20. Lengerke, C. & G.Q. Daley. 2005. Patterning defini-tive hematopoietic stem cells from embryonic stem cells. Exp. Hematol. 33: 971-979.
21. Keller, G. 2005. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19: 1129-1155.
22. Lengerke, C., S. Schmitt, T.V. Bowman, et al. 2008. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell 2: 72-82.
23. Nostro, M.C., X. Cheng, G.M. Keller & P. Gadue. 2008. Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood. Cell Stem Cell 2: 60-71.
24. Gadue, P., T.L. Huber, P.J. Paddison & G.M. Keller. 2006. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA 103: 16806-16811.
25. Lengerke, C., S. McKinney-Freeman, O. Naveiras, et al. 2007. The cdx-hox pathway in hematopoietic stem cell formation from embryonic stem cells. Ann. N. Y. Acad. Sci. 1106: 197-208. (Pubitemid 47443042)
26. McKinney-Freeman, S.L., C. Lengerke, I.H. Jang, et al. 2008. Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes. Blood 111: 4944-4953.
27. Choi, K., M. Kennedy, A. Kazarov, et al. 1998. A common precursor for hematopoietic and endothe-lial cells. Development 125: 725-732.
28. Kennedy, M., M. Firpo, K. Choi, et al. 1997. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature 386: 488-493.
29. Kennedy, M., S.L. D'Souza, M. Lynch-Kattman, et al. 2007. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 109: 2679-2687.
30. Huber, T.L., V. Kouskoff, H.J. Fehling, et al. 2004. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432: 625-630.
31. Cumano, A. & I. Godin. 2007. Ontogeny of the hematopoietic system. Annu. Rev. Immunol. 25: 745-785.
32. Dzierzak, E. 2005. The emergence of definitive hematopoietic stem cells in the mammal. Curr. Opin. Hematol. 12: 197-202. (Pubitemid 40676826)
33. Cho, S.K., T.D. Webber, J.R. Carlyle, et al. 1999. Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. Proc. Natl. Acad. Sci. USA 96: 9797-9802.
34. Schmitt, T.M., R.F. de Pooter, M.A. Gronski, et al. 2004. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat. Immunol. 5: 410-417.
35. Kyba, M., R.C. Perlingeiro & G.Q. Daley. 2002. HoxB4 confers definitive lymphoid-myeloid engraft-ment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109: 29-37.
36. Wang, Y., F. Yates, O. Naveiras, et al. 2005. Embryonic stem cell-derived hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 102: 19081-19086.
37. Yoder, M.C. & K. Hiatt. 1997. Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 89: 2176-2183.
38. Hanna, J., M. Wernig, S. Markoulaki, et al. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
39. Rideout, W.M. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109: 17-27.